FINISH DOSAGE
Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent in fringement and its liability is at buyer's risk.
| ANTI-NEOPLASTICS |
| PRODUCT | FORM | STRENGTH |
| Abiraterone Acetate | Tablet | 250mg/500mg |
| Afatinib Dimaleate | Tablet | 20mg/30mg/40mgs |
| Bortezomib | Injectable | 1.0mg/3.5mg |
| Cabazitaxel | Solution | 60mg:1.5ml |
| Carboplatin | Solution | 50mg:5ml/150mg:15ml/450mg:45ml |
| Carfilzomib | Injectable | 60mg |
| Decitabine | Injectable | 50mg |
| Exemestane | Tablet | 25mg |
| Getifinib | Tablet | 250mg |
| Imatinib Mesylate | Tablet | 100mg/400mg |
| Irinotecan Hydrochloride | Solution | 40mg:2ml/100mg:5ml/300mg:15ml/500mg:25ml |
| Lenalidomide | Capsule | 2.5mg/5mg/7.5mg/10mg/15mg/20mg/25mg |
| Oxaliplatin | Injectable | 50mg/100mg |
| Palbociclib | Capsule | 75mg/100mg/125mg |
| Pemetrexed Disodium | Injectable | 100mg/500mg |
| Paclitaxel for Injection(Albumin Bound) | Injectable | 100mg |
|
|
|
| ANTI-EMETICS |
| PRODUCT | FORM | STRENGTH |
| Aprepitant | Capsule | 80mg/125mg |
| Fosaprepitant Dimeglumine | Injectable | 150mg |
| Tropisetron Hydrochloride | Solution | 2mg:2ml/5mg:5ml |
|
|
|
| CONTRAST MEDIA |
| Iohexol | Injection | 300mg/ml |
| Iohexol | Injection | 350mg/ml |
| Ioversol | Injection | 350mg/ml |
| Ioversol | Injection | 300mg/ml |
| Iopamidol | Injection | 370mg/ml |
| Iodixanol | Injection | 320mg/ml |
|
|
|
|
|
|
| OTHERS |
| PRODUCT | FORM | STRENGTH |
| Cinacalcet Hydrochloride | Tablet | 30mg/60mg/90mg |
| Olanzapine | Tablet | 2.5mg/5mg/7.5mg/10mg/15mg/20mg |
| Solifenacin Succinate | Tablet | 5mg/10mg |
| Tadalafil | Tablet | 2.5mg/5mg/10mg/20mg |
| Tofacitinib Citrate | Tablet | 5mg |
| Pegfilgrastim | Injectable |
|
| Tigecycline | Injectable | 50mgs |
| Ibuprofen | Tablet | 200mg/400mg/600mg/800mg |
| Sevelamer Carbonate | Tablet | 800mg |
|
|
|
| MABS |
| PRODUCT | FORM | STRENGTH |
| Ranibizumab | / | / |
| Trastuzumab | Powder for Injectable | 150mg |